Shares of AngioDynamics (ANGO) have gained 1.1% over the past four weeks to close the last trading session at $9.60, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$15.67 indicates a potential upside of 63.2%.The average comprises three short-term price targets ranging from a low of $15 to a high of$16, with a standard deviation of $0.58. While the lowest estimate indicates an ...